Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction

The American Journal of Cardiology
D C GulbaP R Lichtlen

Abstract

By inducing minimal free-fibrinolytic activity with low dose urokinase, the lag phase of prourokinase can be overcome, and the rate of thrombolysis with this substance can be strongly enhanced. The thrombolytic potency of a combination of 250,000 IU of urokinase and 2 doses of prourokinase (4.5 or 6.5 megaunits) was evaluated in an open-label, nonrandomized dose-finding study. Thirty-one patients participated. With 4.5 megaunits of prourokinase (group 1, 15 patients) patency was demonstrated angiographically at 60 minutes in 33% while with 6.5 megaunits (group II, 16 patients) 75% patency was achieved (p less than 0.01). A second angiogram recorded 24 to 36 hours after thrombolysis revealed reocclusion in 60 versus 8% of primarily patent coronary arteries (p less than 0.05). Hemostatic monitoring in both groups revealed only slight to moderate consumption of fibrinogen (-9 vs -13%), plasminogen (-29 vs -34%) and alpha 2-antiplasmin (-59 vs -63%), and an increase in D-dimers, the split products of cross-linked fibrin, to a maximum of 1.008 +/- 1.211 vs 0.547 +/- 0.684 micrograms/liter. None of these differences was significant. Bleeding complications were more frequently observed in group II (13 vs 37%) (difference not significa...Continue Reading

References

May 1, 1988·The American Journal of Cardiology·C DiefenbachJ Meyer
Apr 1, 1986·Journal of the American College of Cardiology·P W SerruysW J Remme
Sep 20, 1984·The New England Journal of Medicine·G L Laffel, E Braunwald
Sep 13, 1984·The New England Journal of Medicine·G L Laffel, E Braunwald

❮ Previous
Next ❯

Citations

Jun 1, 1990·Clinical Cardiology·C BodeE Haber
Apr 1, 1992·Cardiovascular Drugs and Therapy·M Verstraete
Apr 1, 1990·Postgraduate Medical Journal·L D Smith, D J Coltart
Jul 15, 1991·Thrombosis Research·J HenkinL Sennello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.